Jazz Pharma has agreed a $7.2 billion deal to by GW Pharmaceuticals ... per share, consisting of $200 in cash and $20 in Jazz stock. That is a sizeable premium on GW’s closing share price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback